Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Naoya Fujita, Satoshi Takagi et al.|Clinical Cancer Research|2022Cited by 29
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcomaSatoshi Takagi, Ryohei Katayama, Sumie Koike et al.|Oncogene|2024Cited by 4
Supplementary Figure from Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Naoya Fujita, Satoshi Takagi et al.|Unknown|2023Cited by 0
Data from Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Naoya Fujita, Satoshi Takagi et al.|Unknown|2023Cited by 0
Supplementary Data from Targeting Podoplanin for the Treatment of OsteosarcomaAi Takemoto, Naoya Fujita, Satoshi Takagi et al.|Unknown|2023Cited by 0